Breaking News Instant updates and real-time market news.

BHVN

Biohaven Pharmaceutical

$32.80

-0.75 (-2.24%)

16:17
08/14/18
08/14
16:17
08/14/18
16:17

Biohaven Pharmaceutical reports Q2 EPS ($1.01), consensus ($1.18)

Reports Q2 revenue $0, consensus $0. Reports cash as of June 30 $217.5M, compared to $104.2M as of March 31. This increase primarily reflects the net proceeds of approximately $149.6M from the Company's transaction with Royalty Pharma, offset by payments for operating expenses during the quarter.

  • 30

    Aug

  • 31

    Aug

BHVN Biohaven Pharmaceutical
$32.80

-0.75 (-2.24%)

06/11/18
CANT
06/11/18
INITIATION
Target $42
CANT
Overweight
Biohaven Pharmaceutical initiated with an Overweight at Cantor Fitzgerald
Cantor initiated Biohaven Pharmaceuticals with a Overweight and $42 price target.
06/12/18
CANT
06/12/18
INITIATION
CANT
Cantor expands Specialty Pharmaceuticals coverage with eight names
Cantor Fitzgerald analyst Brandon Folkes last night rolled out coverage on eight names in the Specialty Pharmaceuticals space. He initiated coverage of AcelRx (ACRX), ANI Pharmaceuticals (ANIP), Biohaven Pharmaceutical (BHVN), Collegium Pharmaceutical (COLL), Emergent BioSolutions (EBS), Eagle Pharmaceuticals (EGRX) and Opiant Pharmaceuticals (OPNT) with Overweight ratings. There is still value to be unlocked in these stocks at current valuations with risk/reward profiles that remain to the upside, Folkes told investors in a research note. His top picks are ANI Pharmaceuticals, Emergent BioSolutions and Collegium Pharmaceutical. The analyst rounded out his coverage with a Neutral rating on Momenta (MNTA), saying the recent share rally puts him on the sidelines "for now."
06/19/18
LEHM
06/19/18
NO CHANGE
Target $40
LEHM
Equal Weight
Biohaven price target raised to $40 from $25 at Barclays
Barclays analyst Geoff Meacham raised his price target for Equal Weight-rated Biohaven Pharmaceutical to $40 after reassessing the clinical risk for the company's later-stage program in acute migraine. The analyst now sees a "relatively high" probability of success for rimegepant and slightly higher platform value. The next key value creating point for the company will be the eventual launch, which is not expected until 2020, Meacham tells investors in a research note. As such, he thinks fair value of the acute migraine program, with additional credit to the broader development platform, is accurately reflected in Biohaven's share price.
07/12/18
CANT
07/12/18
NO CHANGE
Target $50
CANT
Overweight
Biohaven price target raised to $50 from $42 at Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes raised his price target for Biohaven Pharmaceutical to $50 and reaffirms an Overweight rating on the shares after meeting this week with CEO Vlad Coric and CFO Jim Engelhart. The Street's focus on rimegepant acute oral calcitonin gene-related peptide data has led to an "under-appreciation of Biohaven's other opportunities to drive long term share holder value beyond current levels," Folkes tells investors in a research note. The analyst sees "multiple catalysts" keeping momentum in the stock through 2018 and 2019.

TODAY'S FREE FLY STORIES

SNAP

Snap

$11.99

0.46 (3.99%)

16:52
04/23/19
04/23
16:52
04/23/19
16:52
Hot Stocks
Snap CEO: New Android OS promising, will 'take time to impact metrics' »

Snap CEO Evan Spiegel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

DAL

Delta Air Lines

$58.23

0.49 (0.85%)

16:52
04/23/19
04/23
16:52
04/23/19
16:52
Hot Stocks
Delta Air Lines CEO sells 30,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jun

SLB

Schlumberger

$45.88

0.04 (0.09%)

16:50
04/23/19
04/23
16:50
04/23/19
16:50
Hot Stocks
Schlumberger CFO Simon Ayat sells 0ver $1.1M in company shares »

Schlumberger CFO Simon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 22

    May

  • 13

    Nov

CBS

CBS

$51.35

0.23 (0.45%)

16:49
04/23/19
04/23
16:49
04/23/19
16:49
Hot Stocks
CBS suspends search for new CEO, extends Ianniello as acting CEO »

Joseph Ianniello has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

MVIS

MicroVision

$0.93

-0.02 (-2.11%)

16:49
04/23/19
04/23
16:49
04/23/19
16:49
Syndicate
MicroVision raises $2M in registered direct offering »

MicroVision announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 30

    May

CBS

CBS

$51.35

0.23 (0.45%)

16:47
04/23/19
04/23
16:47
04/23/19
16:47
Periodicals
CBS suspends search for new CEO, Bloomberg says »

CBS said that Joseph…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 14

    May

FE

FirstEnergy

$40.73

0.14 (0.34%)

16:44
04/23/19
04/23
16:44
04/23/19
16:44
Hot Stocks
Jersey Central Power & Light reaches pact for JCP&L Reliability Plus program »

Jersey Central Power…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 21

    May

NTRA

Natera

$18.99

0.84 (4.63%)

16:42
04/23/19
04/23
16:42
04/23/19
16:42
Hot Stocks
Integrated Core Strategies reports 5.3% passive stake in Natera »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    May

  • 28

    May

CRI

Carter's

$105.13

2.02 (1.96%)

16:42
04/23/19
04/23
16:42
04/23/19
16:42
Initiation
Carter's initiated  »

Carter's initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 16

    May

PLCE

Children's Place

$109.92

2.95 (2.76%)

16:41
04/23/19
04/23
16:41
04/23/19
16:41
Initiation
Children's Place initiated  »

Children's Place…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAC

TransAlta

$6.88

-0.175 (-2.48%)

16:40
04/23/19
04/23
16:40
04/23/19
16:40
Hot Stocks
Mangrove Partners commences action in Ontario court against TransAlta »

Mangrove Partners, one of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

CP

Canadian Pacific

$219.33

0.215 (0.10%)

16:39
04/23/19
04/23
16:39
04/23/19
16:39
Hot Stocks
Breaking Hot Stocks news story on Canadian Pacific »

Canadian Pacific drops 5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 05

    Jun

  • 13

    Nov

LLY

Eli Lilly

$117.51

2.07 (1.79%)

16:39
04/23/19
04/23
16:39
04/23/19
16:39
Upgrade
Eli Lilly rating change  »

Eli Lilly upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 30

    Apr

  • 04

    May

  • 06

    May

  • 07

    May

  • 08

    May

  • 09

    May

  • 18

    May

16:38
04/23/19
04/23
16:38
04/23/19
16:38
General news
API crude inventories for week of April 19 »

API reports that crude…

MTH

Meritage Homes

$49.75

1.275 (2.63%)

16:38
04/23/19
04/23
16:38
04/23/19
16:38
Earnings
Meritage Homes sees FY19 EPS $4.65-$4.95, consensus $4.69 »

CEO Steven Hilton said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 17

    May

HZN

Horizon Global

$2.77

0.04 (1.47%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Hot Stocks
Horizon Global board approves amendment to declassify board structure »

Horizon Global…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BURL

Burlington Stores

$161.96

1.76 (1.10%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Earnings
Burlington Stores narrows Q1 EPS view to $1.21-$1.25 from $1.21-$1.31 »

Q1 consensus $1.29.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

TRMK

Trustmark

$34.47

0.7 (2.07%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Earnings
Trustmark reports Q1 EPS 51c, consensus 52c »

Reports Q1 net interest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

  • 24

    Apr

PRK

Park National

$95.63

2.2 (2.35%)

16:36
04/23/19
04/23
16:36
04/23/19
16:36
Hot Stocks
Park National elects CEO Trautman as chairman and EVP Miller as president »

The board of directors…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

MTH

Meritage Homes

$49.75

1.275 (2.63%)

16:35
04/23/19
04/23
16:35
04/23/19
16:35
Earnings
Meritage Homes reports Q1 EPS 65c, consensus 64c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 17

    May

LRN

K12

$36.23

0.805 (2.27%)

16:35
04/23/19
04/23
16:35
04/23/19
16:35
Earnings
K12 sees FY19 revenue $1.005B-$1.01B, consensus $1.01B »

Sees FY19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

LRN

K12

$36.23

0.805 (2.27%)

16:34
04/23/19
04/23
16:34
04/23/19
16:34
Earnings
K12 reports Q3 EPS 44c, consensus 37c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Apr

ROST

Ross Stores

$97.85

0.06 (0.06%)

, BURL

Burlington Stores

$161.96

1.76 (1.10%)

16:34
04/23/19
04/23
16:34
04/23/19
16:34
Hot Stocks
Burlington Stores CEO Thomas Kingsbury to step down, Michael O'Sullivan succeeds »

Burlington Stores (BURL)…

ROST

Ross Stores

$97.85

0.06 (0.06%)

BURL

Burlington Stores

$161.96

1.76 (1.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

NAVI

Navient

$12.45

0.38 (3.15%)

16:33
04/23/19
04/23
16:33
04/23/19
16:33
Earnings
Navient reports Q1 adjusted EPS 58c, consensus 44c »

Reports Q1 revenue $257M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 02

    May

KALU

Kaiser Aluminum

$107.59

2 (1.89%)

, BA

Boeing

$374.04

-0.98 (-0.26%)

16:33
04/23/19
04/23
16:33
04/23/19
16:33
Hot Stocks
Kaiser Aluminum says Boeing 737 build rate reduction introduces uncertainty »

"The recent…

KALU

Kaiser Aluminum

$107.59

2 (1.89%)

BA

Boeing

$374.04

-0.98 (-0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 24

    Apr

  • 29

    Apr

  • 29

    May

  • 05

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.